In a surprise, Hans Bishop takes over as CEO of Grail, the liquid biopsy startup
JUNO THERAPEUTICS
Bishop, who led Juno until it was sold to Celgene, will be the third chief executive Grail has had since it was founded in 2015.
¿Cómo sabemos que el cambio climático es real?
Hace 34 minutos
.png)
No hay comentarios:
Publicar un comentario